CA Stock MarketDetailed Quotes
XRX XORTX Therapeutics Inc
- 4.800
- 0.0000.00%
15min DelayTrading Nov 4 16:00 ET
59.00MMarket Cap-13636P/E (TTM)
0.000High0.000Low0Volume0.000Open4.800Pre Close0.00Turnover5.15052wk High0.00%Turnover Ratio12.29MShares3.18052wk Low-0.352EPS TTM52.74MFloat Cap9.979Historical HighLossP/E (Static)10.99MShs Float0.352Historical Low-0.235EPS LYR0.00%Amplitude--Dividend TTM17.78P/B1Lot Size--Div YieldTTM
XORTX Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | (Q3)Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -344.41%-861.99K | 41.11%-1.17M | -191.85%-728.4K | 1,597.51%1.57M | -1,038.59%-119.64K | -383.14%-193.96K | -1,593.92%-1.99M | 83.95%-249.58K | 15.62%-104.93K | 106.40%12.75K |
| Net income from continuing operations | 41.55%-218.45K | -6,440.44%-2.17M | -104.04%-1.28M | -138.95%-452.73K | -222.26%-424.91K | -140.47%-373.74K | 78.26%-33.23K | 83.33%-629.58K | -28.48%-189.47K | 57.03%-131.85K |
| Operating gains losses | -1,770.32%-664.86K | 1,009.34%1.32M | -363.66%-89.81K | -326.58%-28.23K | 930.09%43.4K | 198.27%39.8K | -1,173.31%-144.79K | 172.59%34.06K | 138.35%12.46K | -147.25%-5.23K |
| Depreciation and amortization | -14.17%4.37K | -15.96%4.24K | 2.71%20.44K | 2.62%5.14K | 2.92%5.15K | 2.70%5.1K | 2.60%5.05K | 3.02%19.9K | 1.77%5.01K | 2.77%5.01K |
| Asset impairment expenditure | ---- | ---- | --64.56K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Remuneration paid in stock | ---- | ---- | ---95.49K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Remuneration paid in stock | -52.27%90.45K | 2,917.09%202.99K | 1,015.03%293.44K | -21.12%6.75K | 768.31%90.44K | 1,278.16%189.52K | 205.03%6.73K | -90.43%26.32K | -1.12%8.56K | -45.13%10.42K |
| Other non cashItems | --0 | 17,714.73%75K | -48.35%846 | --0 | --0 | 4.68%425 | 6.05%421 | -99.94%1.64K | -98.87%420 | 4.53%415 |
| Change In working capital | -33.48%-73.51K | 67.31%-595.07K | 21.52%362.21K | 3,465.36%2.07M | 24.10%166.27K | -166.51%-55.07K | -7,951.94%-1.82M | 144.22%298.08K | 1,129.02%58.1K | 85.10%133.99K |
| -Change in receivables | ---- | 36.28%-89.66K | -390.76%-43K | 698.77%42.99K | ---- | ---- | -17,450.31%-140.71K | 173.72%14.79K | 338.04%5.38K | -243.78%-113.62K |
| -Change in prepaid assets | 69.91%-63.99K | --0 | ---- | ---- | --212.62K | ---212.62K | ---1.61M | ---- | ---- | --0 |
| -Change in payables and accrued expense | -689.01%-99.18K | -252.73%-505.41K | 14.70%405.21K | 300.95%492.02K | -83.99%39.64K | 142.73%16.84K | -740.47%-143.29K | 1,699.17%353.29K | 1,656.07%122.71K | 3,830.19%247.61K |
| -Change in other working capital | ---- | ---- | ---- | ---- | --0 | --0 | --70K | ---70K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -344.41%-861.99K | 41.11%-1.17M | -191.85%-728.4K | 1,597.51%1.57M | -1,038.59%-119.64K | -383.14%-193.96K | -1,593.92%-1.99M | 83.95%-249.58K | 15.62%-104.93K | 106.40%12.75K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -184.86%-10.28K | 94.28%-186 | -103.92%-14.35K | -1,732.26%-2.84K | -26.16%-4.65K | -12.97%-3.61K | -3.25K | 95.45%-7.04K | 96.09%-155 | 58.49%-3.69K |
| Net intangibles purchas and sale | -184.86%-10.28K | 94.28%-186 | -103.92%-14.35K | -1,732.26%-2.84K | -26.16%-4.65K | -12.97%-3.61K | ---3.25K | 82.87%-7.04K | 96.09%-155 | 90.06%-3.69K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -184.86%-10.28K | 94.28%-186 | -103.92%-14.35K | -1,732.26%-2.84K | -26.16%-4.65K | -12.97%-3.61K | ---3.25K | 95.45%-7.04K | 96.09%-155 | 58.49%-3.69K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -22.97K | 188.42%7.04M | 1,449.32%855.41K | -2,973.14%-1.59M | 0 | 0 | 2.44M | -97.11%55.21K | 55.21K | 0 |
| Net common stock issuance | --0 | 146.21%6.12M | --900K | ---1.59M | --0 | --0 | --2.49M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | --1.01M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net other financing activities | ---22.97K | -109.12%-93.25K | -180.77%-44.59K | --0 | --0 | --0 | ---44.59K | 212.39%55.21K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---22.97K | 188.42%7.04M | 1,449.32%855.41K | -2,973.14%-1.59M | --0 | --0 | --2.44M | -97.11%55.21K | --55.21K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 1,082.83%6.04M | 192.20%171.27K | -77.46%58.61K | 74.30%189.09K | 215.19%313.39K | 257.89%510.96K | -77.46%58.61K | 319.80%260.02K | -72.06%108.49K | -83.33%99.43K |
| Current changes in cash | -353.12%-895.23K | 1,198.24%5.87M | 155.94%112.66K | 64.27%-17.82K | -1,472.22%-124.3K | -355.87%-197.57K | 485.79%452.34K | -201.68%-201.41K | 61.13%-49.87K | 104.35%9.06K |
| End cash Position | 1,542.86%5.15M | 1,082.83%6.04M | 192.20%171.27K | 192.20%171.27K | 74.30%189.09K | 215.19%313.39K | 257.89%510.96K | -77.46%58.61K | -77.46%58.61K | -72.06%108.49K |
| Free cash from | -341.50%-872.27K | 41.20%-1.17M | -189.44%-742.75K | 1,592.60%1.57M | -1,472.22%-124.3K | -355.87%-197.57K | -1,596.69%-1.99M | 83.93%-256.62K | 18.10%-105.09K | 104.35%9.06K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg